Effect of Lactobacillus sakei supplementation in children with atopic eczema-dermatitis syndrome

Annals of Allergy, Asthma and Immunology

Volumn 104, Issue 4, 2010, Pages 343-348

  Woo, Sung Il ^a   Kim, Ji Yoon ^a   Lee, Yong Ju ^a   Kim, Nam Shik ^a   Hahn, Youn Soo ^a  

^a Chungbuk National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CORTICOSTEROID; PLACEBO; PROBIOTIC AGENT;

ARTICLE; ATOPIC DERMATITIS; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HUMAN; LACTOBACILLUS SAKEI; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADRENAL CORTEX HORMONES; CHEMOKINE CCL17; CHEMOKINE CCL27; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LACTOBACILLUS; MALE; PROBIOTICS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77950011957     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2010.01.020     Document Type: Article

References (29)

1. Boguniewicz M., and Leung D.Y. Atopic dermatitis. J Allergy Clin Immunol 117 suppl 2 (2006) S475-S480
2. Björkstén B., Sepp E., Julge K., Voor T., and Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 108 (2001) 516-520
3. Matricardi P.M., Rosmini F., Riondino S., et al. Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study. BMJ 320 (2000) 412-417
4. Salminen S., Bouley C., Boutron-Ruault M.C., et al. Functional food science and gastrointestinal physiology and function. Br J Nutr 80 suppl 1 (1998) S147-S171
5. Kalliomäki M., Salminen S., Arvilommi H., et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357 (2001) 1076-1079
6. Kalliomäki M., Salminen S., Poussa T., Arvilommi H., and Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361 (2003) 1869-1871
7. Isolauri E., Arvola T., Sutas Y., Moilanen E., and Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy 30 (2000) 1604-1610
8. Viljanen M., Savilahti E., Haahtela T., et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 60 (2005) 494-500
9. Weston S., Halbert A., Richmond P., and Prescott S.L. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child 90 (2005) 892-897
10. Brouwer M.L., Wolt-Plompen S.A., Dubois A.E., et al. No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy 36 (2006) 899-906
11. Gruber C., Wendt M., Sulser C., et al. Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy. Allergy 62 (2007) 1270-1276
12. Passeron T., Lacour J.P., Fontas E., and Ortonne J.P. Prebiotics and synbiotics: two promising approaches for the treatment of atopic dermatitis in children above 2 years. Allergy 61 (2006) 431-437
13. Rosenfeldt V., Benfeldt E., Nielsen S.D., et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 111 (2003) 389-395
14. Sistek D., Kelly R., Wickens K., et al. Is the effect of probiotics on atopic dermatitis confined to food sensitized children?. Clin Exp Allergy 36 (2006) 629-633
15. Hanifin J.M. Atopic dermatitis in infants and children. Pediatr Clin North Am 38 (1991) 763-789
16. Meggitt S.J., Gray J.C., and Reynolds N.J. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial. Lancet 367 (2006) 839-846
17. Hon K.L., Leung T.F., Wong Y., and Fok T.F. Lesson from performing SCORADs in children with atopic dermatitis: subjective symptoms do not correlate well with disease extent or intensity. Int J Dermatol 45 (2006) 728-730
18. Hijnen D., De Bruin-Weller M., Oosting B., et al. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol 113 (2004) 334-340
19. Kakinuma T., Nakamura K., Wakugawa M., et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 107 (2001) 535-541
20. Lee J., Seto D., and Bielory L. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J Allergy Clin Immunol 121 (2008) 116-121
21. David T.J., and Cambridge G.C. Bacterial infection and atopic eczema. Arch Dis Child 61 (1986) 20-23
22. Hoeger P.H., Lenz W., Boutonnier A., and Fournier J.M. Staphylococcal skin colonization in children with atopic dermatitis: prevalence, persistence, and transmission of toxigenic and nontoxigenic strains. J Infect Dis 165 (1992) 1064-1068
23. Monti G., Tonetto P., Mostert M., and Oggero R. Staphylococcus aureus skin colonization in infants with atopic dermatitis. Dermatology 193 (1996) 83-87
24. Park C.W., Youn M., Jung Y.M., et al. New functional probiotic Lactobacillus sakei probio 65 alleviates atopic symptoms in the mouse. J Med Food 11 (2008) 405-412
25. Mainardi T., Kapoor S., and Bielory L. Complementary and alternative medicine: herbs, phytochemicals and vitamins and their immunologic effects. J Allergy Clin Immunol 123 (2009) 283-294
26. Campbell J.J., Haraldsen G., Pan J., et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 400 (1999) 776-780
27. Morales J., Homey B., Vicari A.P., et al. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci U S A 96 (1999) 14470-14475
28. Horikawa T., Nakayama T., Hikita I., et al. IFN-γ-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis. Int Immunol 14 (2002) 767-773
29. Thestrup-Pedersen K. Clinical aspects of atopic dermatitis. Clin Exp Dermatol 25 (2000) 535-543